STRYKER FLEXIBLE URETEROSCOPE

K031278 · Stryker Endoscopy · FGB · Oct 16, 2003 · Gastroenterology, Urology

Device Facts

Record IDK031278
Device NameSTRYKER FLEXIBLE URETEROSCOPE
ApplicantStryker Endoscopy
Product CodeFGB · Gastroenterology, Urology
Decision DateOct 16, 2003
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 876.1500
Device ClassClass 2

Intended Use

The Stryker Flexible Ureteroscope is indicated for use during minimally invasive urological procedures accessed through natural body orifices and is intended for, but not limited to transurethral examination of the upper urinary tract including the ureter, and kidney and, utilizing additional accessories for various diagnostic and therapeutic procedures.

Device Story

Flexible ureteroscope for visualization of upper urinary tract; used during minimally invasive urological procedures via natural body orifices. Device enables transurethral examination of ureter and kidney; facilitates diagnostic and therapeutic interventions when paired with additional accessories. Operated by physicians in clinical settings. Device provides direct visualization; assists clinical decision-making by allowing inspection of urinary tract anatomy and guidance for accessory use. Benefits include minimally invasive access to upper urinary tract.

Clinical Evidence

No clinical data provided; substantial equivalence supported by bench testing and adherence to established safety standards.

Technological Characteristics

Flexible endoscope; materials validated for biocompatibility per ISO 10993. Complies with EN 60601-2-18 for electrical safety and leakage current. Sterilization via Ethylene Oxide (EN 550).

Indications for Use

Indicated for patients undergoing minimally invasive urological procedures via natural body orifices for transurethral examination of the upper urinary tract, including ureter and kidney, and for diagnostic/therapeutic procedures using accessories.

Regulatory Classification

Identification

An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.

Special Controls

*Classification* —(1)*Class II (special controls).* The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ OCT 1 6 2003 Image /page/0/Picture/1 description: The image shows a sequence of handwritten characters and numbers. The sequence starts with the letter 'K', followed by the number '0', then the number '3'. After that, the numbers '1', '2', '7', and '8' are written in succession. #### 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS ### Device Name | Classification Name: | Endoscopes and Accessories | |------------------------|-------------------------------| | Common and Usual Name: | Endoscope, Ureteroscope | | Proprietary Name: | Stryker Flexible Ureteroscope | This 510(k) summary and effectiveness is being submitted in accordance with requirements of SMDA 1990. The Stryker Flexible Ureteroscope is substantially equivalent in safety and efficacy to the currently marketed Karl Storz Uretero Fiberscope (KSEA11273) as cleared under 510(k) #K970427. The Stryker Flexible Ureteroscope is a newly marketed product for Stryker Endoscopy and is based upon technology used in endoscope production and clinical applications for over 30 years. All applicable materials are tested and validated for biocompatibility according to the voluntary standard ISO 10993 "Biological Evaluation of Medical Devices". The cleaning, disinfection, and sterilization methods will be equivalent to those for which the Karl Storz Uretero-Fiberscope is currently validated. The Stryker Flexible Ureteroscope will be electrically isolated from the patient and the physician, will meet safety standards for leakage current, will not present a thermal hazard to the physician, and will meet all applicable safety standards established by EN 60601-2-18: Particular Requirements for the Safety of Endoscopic Equipment. The Stryker Flexible Ureteroscope will conform to the following voluntary standards: EN 550 Ethylene Oxide Sterilization; ISO 10993: Biological Evaluation of Medical Devices. There are no significant technological differences between the Stryker Flexible Ureteroscope and the predicate Karl Storz Uretero-Fiberscope. Clinical data and laboratory testing demonstrate that the differences do not raise new issues of safety and effectiveness of the proposed device. Therefore, the Stryker Flexible Ureteroscope is substantially equivalent to the currently marketed Karl Storz Uretero-Fiberscope. Contact: CTK Christopher L. Cook Quality Engineer Stryker Endoscopy 4/17/03 Date Date {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS). The seal features a stylized eagle with three stripes forming its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 # OCT 1 6 2003 Mr. Christopher L. Cook Quality Engineer Stryker® Endoscopy 5900 Optical Court SAN JOSE CA 95138 Re: K031278 Trade/Device Name: Stryker Flexible Ureteroscope Regulation Number: 21 CFR §876.1500 Regulation Name: Endoscope and accessories Regulatory Class: II Product Code: 78 FGB Dated: August 20, 2003 Received: August 21, 2003 Dear Mr. Cook: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050. {2}------------------------------------------------ l'age 2 This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of the letter: | 8xx.1xxx | (301) 594-4591 | |----------------------------------|----------------| | 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 | | 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 | | 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 | | Other | (301) 594-4692 | Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html. Sincerely yours, Nancy C. Brogdon Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ Stryker Flexible Ureteroscope K031270 Koz 12 78 ## Appendix H #### Indications for use statement 18 April, 2003 510(k) Number: K031270 Device Name: Stryker Flexible Ureteroscope ## INDICATION FOR USE: The Stryker Flexible Ureteroscope is indicated for use during minimally invasive urological procedures accessed through natural body orifices and is intended for, but not limited to transurethral examination of the upper urinary tract including the ureter, and kidney and, utilizing additional accessories for various diagnostic and therapeutic procedures. (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use X (Per 21 CFR 801.109) OR Over Nancy C Brogdon (Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devis 510(k) Number Over-the-Counter Use
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%